In patients receiving variable doses of GCs, intensive insulin therapy offers greater flexibility, as insulin dosing can be rapidly adjusted in response to changing steroid requirements
[DOI] [PubMed] [Google Scholar] 162.Jahnke G.D., et al
Liraglutides patent expires this year in the US and Europe, Price Negotiation : With more options available in the market, insurers and pharmacy benefits managers may be able to negotiate lower prices with drug manufacturers
In the SGLT2i group, 101 participants were hospitalised (mean number of hospitalisations=2.7, median number of hospitalisations=2), with a mean and median length of stay of 2.4 and 2 days, respectively
Significant weight loss is one of the hallmarks of GLP-1 drugs, but some people have claimed that their hair is vanishing along with the excess pounds